За ову презентацију коришћен је материјал из презентације чији су аутори Душан Станковић, Александра Станковић, Анђелко Тешмановић; ОШ “Браћа Рибар”, Доња Борина
http://www.theheart.org/web_slides/1135309.do
A study on Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients (ADVANCE)
The document summarizes key findings from the ADVANCE trial, the largest clinical trial in type 2 diabetes. The ADVANCE trial involved over 11,000 patients across 20 countries and found that intensive glycemic control using gliclazide modified release provided significant reductions in microvascular and macrovascular complications compared to standard care, including a 10% reduction in combined microvascular and macrovascular events. Intensive control with gliclazide MR also resulted in unique renal protection and the lowest rates of hypoglycemia compared to other major trials.
За ову презентацију коришћен је материјал из презентације чији су аутори Душан Станковић, Александра Станковић, Анђелко Тешмановић; ОШ “Браћа Рибар”, Доња Борина
http://www.theheart.org/web_slides/1135309.do
A study on Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients (ADVANCE)
The document summarizes key findings from the ADVANCE trial, the largest clinical trial in type 2 diabetes. The ADVANCE trial involved over 11,000 patients across 20 countries and found that intensive glycemic control using gliclazide modified release provided significant reductions in microvascular and macrovascular complications compared to standard care, including a 10% reduction in combined microvascular and macrovascular events. Intensive control with gliclazide MR also resulted in unique renal protection and the lowest rates of hypoglycemia compared to other major trials.
Takmičenje na portalu www.nasaskola.net
"biramo najbolju lekciju"
februar 2012. godine,
Dositej Obradović,
Srpski jezik,
Anđelija Stoilković, I-1,
Kristina Mitić,
Prva niška gimnazija "Stevan Sremac"
1) The ACCOMPLISH trial found that initiating treatment for high-risk hypertension with a single-pill combination of an ACE inhibitor and calcium channel blocker reduced cardiovascular events by 20% compared to an ACE inhibitor and diuretic combination.
2) The combination of perindopril and amlodipine has been shown to better control blood pressure throughout the day and night, reduce central blood pressure, and decrease blood pressure variability compared to other regimens.
3) In addition to blood pressure control, the perindopril-amlodipine combination provides protection of target organs by reducing the risk of new onset diabetes by 30% and peripheral arterial disease by 35%.
The document summarizes the results of the HYVET trial, which provided the first clear evidence for treating hypertension in patients aged 80 or over. The trial found that treating hypertensive patients aged 80 or over with the Natrilix SR-based regimen reduced total mortality by 21%, all strokes by 30%, fatal strokes by 39%, and heart failure by 64% compared to placebo. The treatment was also well-tolerated with few serious adverse events reported.
http://www.theheart.org/web_slides/1283563.do
A study on Anglo-Scandinavian Cardiac Outcomes--Lipid Lowering Arm (ASCOT-LLA) designed to assess the effect on risk of normal MI and fatal CHD of two treatment strategies.
1) The document summarizes the results of a large clinical trial testing the fixed-dose combination drug Preterax (perindopril and indapamide) for the treatment of type 2 diabetes patients.
2) The trial found that Preterax reduced the risk of cardiovascular mortality by 18%, total mortality by 14%, and the combined outcome of major macrovascular or microvascular events by 9% compared to placebo.
3) The beneficial effects of Preterax were consistent across patient subgroups and backgrounds in ancillary treatments.
This document discusses the management of hypertensive heart disease. It notes that hypertension accounts for about 25% of heart failure cases and uncontrolled hypertension can lead to left ventricular hypertrophy and dysfunction. For the case of the 78-year-old woman admitted with congestive heart failure, the key points are that she is elderly with signs of heart failure, accelerated hypertension, and normal left ventricular function. Her treatment should focus on controlling heart failure, hypertension, and any ischemia through medications like diuretics, nitrates, and antihypertensives.
This document discusses angiotensin II receptor blockers (ARBs), which are used to treat hypertension and other conditions. It lists the major ARBs available worldwide and in Bangladesh specifically. Data on the top selling ARBs in Bangladesh from 2001-2012 shows losartan as the highest selling, with strong growth from olmesartan and irbesartan as well. Clinical trials findings suggest azilsartan may provide better blood pressure control than other ARBs. A price comparison table shows the monthly and annual costs of common ARBs.
Recent advances in treatment of Hypertension -- Drugs inhibiting RAAS, Diuret...Deepthivagge
This document summarizes guidelines for diagnosing hypertension, mechanisms of action for antihypertensive drug classes, and clinical trials of new antihypertensive drugs. The JNC 7 criteria classify blood pressure and define thresholds for normal, prehypertension, and stages 1 and 2 of hypertension. Drugs that inhibit the renin-angiotensin-aldosterone system lower blood pressure by blocking counter-regulatory mechanisms. New direct renin inhibitors and their mechanisms of action are discussed along with clinical trial results comparing their efficacy to ACE inhibitors and ARBs. Calcium channel blockers mechanisms and advantages are also summarized, along with current uses and new drugs in clinical trials.
2. Tekst je napisan u prvom licu i predstavlja
autorovo svedočenje o sopstvenom životu.
U autobiografiji važna je namera autora da
istinito opiše sopstveni život i predstavi ga u
njegovoj celovitosti.
Prosvetiteljska autobiografija- uobičajeno je
pisana sa namerom da među čitaocima
podstakne izazove i lepote učenja, vrednosti
obrazovanja, morala i vaspitanja.
3. - kroz učenje i obrazovanje
stiže se do kvalitetnog života
- ne treba biti besposlen, uvek
možeš da pročitaš neku knjigu
i naučiš nešto novo
4. - čovek koji je obrazovan i učen, svi ga poštuju, jer
ljudi poštuju znanje, a ne novac
5. - džaba svo bogatstvo, ako čovek nema znanja
- čovek vredi onoliko koliko zna
6. - obrazovani ljudi umeju da se snađu u životu
- njihova dela moraju biti dobra jer su
postignuta znanjem
7. - kroz učenje stečeš i poštenje
- nauka treba da bude cenjena više od
bogatstva i položaja
8. - znanjem i učenjem dobijaš
priliku da pošteno zaslužiš lep
život;
- kad imaš znanja (kad si učen)
tad možeš imati sve!
10. Moraš da stičeš nauku, znanje, kako bi mogao
da budeš bitan i dođeš u mogućnost da menjaš
svet jer je to tako i onima koji su rođeni da
vladaju i menjaju svet (carevi, kraljevi).
11. Drača Ivana
Stanković Milana
Bokun Ivana
Stojaković Nataša
Pavlov Jelena
Maksimović Saška
Sokić Aleksej
Icić Maja
Stojanovski Sanja
Tomić Katica
II3 (septembar 2014.)